Selected research
Industry Research
Pain-Relieving Lidocaine Patch Industry Research Report 2026
Market perspective
The global Pain-Relieving Lidocaine Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pain-Relieving Lidocaine Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pain-Relieving Lidocaine Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pain-Relieving Lidocaine Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pain-Relieving Lidocaine Patch include Mylan NV, Pfizer, Teikoku Seiyaku Company, TEH SENG Pharmaceutical, IBSA Institut Biochimique, GlaxoSmithKline, Endo Pharmaceuticals, Allergan and Acorda Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pain-Relieving Lidocaine Patch market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pain-Relieving Lidocaine Patch Market by Company
Mylan NV
Pfizer
Teikoku Seiyaku Company
TEH SENG Pharmaceutical
IBSA Institut Biochimique
GlaxoSmithKline
Endo Pharmaceuticals
Allergan
Acorda Therapeutics
Pain-Relieving Lidocaine Patch Segment by Type
Aqueous
Non-aqueous
Pain-Relieving Lidocaine Patch Segment by Application
Drugstore
Hospitals
Others
Pain-Relieving Lidocaine Patch Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain-Relieving Lidocaine Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain-Relieving Lidocaine Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain-Relieving Lidocaine Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pain-Relieving Lidocaine Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pain-Relieving Lidocaine Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pain-Relieving Lidocaine Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aqueous
- Non-aqueous
Applications
- Drugstore
- Hospitals
- Others
Companies covered
- Mylan NV
- Pfizer
- Teikoku Seiyaku Company
- TEH SENG Pharmaceutical
- IBSA Institut Biochimique
- GlaxoSmithKline
- Endo Pharmaceuticals
- Allergan
- Acorda Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pain-Relieving Lidocaine Patch Market Size (2021-2032)
- 2.2.2 Global Pain-Relieving Lidocaine Patch Sales (2021-2032)
- 2.2.3 Global Pain-Relieving Lidocaine Patch Market Average Price (2021-2032)
- 2.3 Pain-Relieving Lidocaine Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aqueous
- 2.3.3 Non-aqueous
- 2.4 Pain-Relieving Lidocaine Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drugstore
- 2.4.3 Hospitals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pain-Relieving Lidocaine Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pain-Relieving Lidocaine Patch Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pain-Relieving Lidocaine Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Pain-Relieving Lidocaine Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Pain-Relieving Lidocaine Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pain-Relieving Lidocaine Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pain-Relieving Lidocaine Patch, Product Type & Application
- 3.8 Global Manufacturers of Pain-Relieving Lidocaine Patch, Established Date
- 3.9 Global Pain-Relieving Lidocaine Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mylan NV
- 4.1.1 Mylan NV Company Information
- 4.1.2 Mylan NV Business Overview
- 4.1.3 Mylan NV Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Mylan NV Pain-Relieving Lidocaine Patch Product Portfolio
- 4.1.5 Mylan NV Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Pain-Relieving Lidocaine Patch Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Teikoku Seiyaku Company
- 4.3.1 Teikoku Seiyaku Company Company Information
- 4.3.2 Teikoku Seiyaku Company Business Overview
- 4.3.3 Teikoku Seiyaku Company Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Teikoku Seiyaku Company Pain-Relieving Lidocaine Patch Product Portfolio
- 4.3.5 Teikoku Seiyaku Company Recent Developments
- 4.4 TEH SENG Pharmaceutical
- 4.4.1 TEH SENG Pharmaceutical Company Information
- 4.4.2 TEH SENG Pharmaceutical Business Overview
- 4.4.3 TEH SENG Pharmaceutical Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TEH SENG Pharmaceutical Pain-Relieving Lidocaine Patch Product Portfolio
- 4.4.5 TEH SENG Pharmaceutical Recent Developments
- 4.5 IBSA Institut Biochimique
- 4.5.1 IBSA Institut Biochimique Company Information
- 4.5.2 IBSA Institut Biochimique Business Overview
- 4.5.3 IBSA Institut Biochimique Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 IBSA Institut Biochimique Pain-Relieving Lidocaine Patch Product Portfolio
- 4.5.5 IBSA Institut Biochimique Recent Developments
- 4.6 GlaxoSmithKline
- 4.6.1 GlaxoSmithKline Company Information
- 4.6.2 GlaxoSmithKline Business Overview
- 4.6.3 GlaxoSmithKline Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GlaxoSmithKline Pain-Relieving Lidocaine Patch Product Portfolio
- 4.6.5 GlaxoSmithKline Recent Developments
- 4.7 Endo Pharmaceuticals
- 4.7.1 Endo Pharmaceuticals Company Information
- 4.7.2 Endo Pharmaceuticals Business Overview
- 4.7.3 Endo Pharmaceuticals Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Endo Pharmaceuticals Pain-Relieving Lidocaine Patch Product Portfolio
- 4.7.5 Endo Pharmaceuticals Recent Developments
- 4.8 Allergan
- 4.8.1 Allergan Company Information
- 4.8.2 Allergan Business Overview
- 4.8.3 Allergan Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Allergan Pain-Relieving Lidocaine Patch Product Portfolio
- 4.8.5 Allergan Recent Developments
- 4.9 Acorda Therapeutics
- 4.9.1 Acorda Therapeutics Company Information
- 4.9.2 Acorda Therapeutics Business Overview
- 4.9.3 Acorda Therapeutics Pain-Relieving Lidocaine Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Acorda Therapeutics Pain-Relieving Lidocaine Patch Product Portfolio
- 4.9.5 Acorda Therapeutics Recent Developments
5 Global Pain-Relieving Lidocaine Patch Market Scenario by Region
- 5.1 Global Pain-Relieving Lidocaine Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pain-Relieving Lidocaine Patch Sales by Region: 2021-2032
- 5.2.1 Global Pain-Relieving Lidocaine Patch Sales by Region: 2021-2026
- 5.2.2 Global Pain-Relieving Lidocaine Patch Sales by Region: 2027-2032
- 5.3 Global Pain-Relieving Lidocaine Patch Revenue by Region: 2021-2032
- 5.3.1 Global Pain-Relieving Lidocaine Patch Revenue by Region: 2021-2026
- 5.3.2 Global Pain-Relieving Lidocaine Patch Revenue by Region: 2027-2032
- 5.4 North America Pain-Relieving Lidocaine Patch Market Facts & Figures by Country
- 5.4.1 North America Pain-Relieving Lidocaine Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pain-Relieving Lidocaine Patch Sales by Country (2021-2032)
- 5.4.3 North America Pain-Relieving Lidocaine Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pain-Relieving Lidocaine Patch Market Facts & Figures by Country
- 5.5.1 Europe Pain-Relieving Lidocaine Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pain-Relieving Lidocaine Patch Sales by Country (2021-2032)
- 5.5.3 Europe Pain-Relieving Lidocaine Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pain-Relieving Lidocaine Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pain-Relieving Lidocaine Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pain-Relieving Lidocaine Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pain-Relieving Lidocaine Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pain-Relieving Lidocaine Patch Market Facts & Figures by Country
- 5.7.1 South America Pain-Relieving Lidocaine Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pain-Relieving Lidocaine Patch Sales by Country (2021-2032)
- 5.7.3 South America Pain-Relieving Lidocaine Patch Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pain-Relieving Lidocaine Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pain-Relieving Lidocaine Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pain-Relieving Lidocaine Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pain-Relieving Lidocaine Patch Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pain-Relieving Lidocaine Patch Sales by Type (2021-2032)
- 6.1.1 Global Pain-Relieving Lidocaine Patch Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pain-Relieving Lidocaine Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Pain-Relieving Lidocaine Patch Revenue by Type (2021-2032)
- 6.2.1 Global Pain-Relieving Lidocaine Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pain-Relieving Lidocaine Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Pain-Relieving Lidocaine Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pain-Relieving Lidocaine Patch Sales by Application (2021-2032)
- 7.1.1 Global Pain-Relieving Lidocaine Patch Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pain-Relieving Lidocaine Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Pain-Relieving Lidocaine Patch Revenue by Application (2021-2032)
- 7.2.1 Global Pain-Relieving Lidocaine Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pain-Relieving Lidocaine Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Pain-Relieving Lidocaine Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pain-Relieving Lidocaine Patch Value Chain Analysis
- 8.1.1 Pain-Relieving Lidocaine Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pain-Relieving Lidocaine Patch Production Mode & Process
- 8.2 Pain-Relieving Lidocaine Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pain-Relieving Lidocaine Patch Distributors
- 8.2.3 Pain-Relieving Lidocaine Patch Customers
9 Global Pain-Relieving Lidocaine Patch Analyzing Market Dynamics
- 9.1 Pain-Relieving Lidocaine Patch Industry Trends
- 9.2 Pain-Relieving Lidocaine Patch Industry Drivers
- 9.3 Pain-Relieving Lidocaine Patch Industry Opportunities and Challenges
- 9.4 Pain-Relieving Lidocaine Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst